Genmab B.V.
|
Genmab B.V. Employees in Amsterdam: 130 |
Company Profile
Genmab is headquartered in Copenhagen (Denmark) and has operations in Utrecht (The Netherlands), Princeton (US), Brooklin Park (US) and Stevenage (UK). From its Research & Discovery facilities in Utrecht, The Netherlands, the preclinical activities take place. After characterization and optimisation of lead candidates, the human antibodies are clinically evaluated by Genmab A/S, the corporate headquarter in Copenhagen, Denmark. This location also accommodates the regulatory and medical departments. From Genmab Inc. in Princeton, USA the US clinical activities are coordinated. From Genmab Ltd. in Hitchin, UK the UK clinical activities are coordinated.Science and Technologies or Services
Genmab uses a combination of innovative technology platforms in multidisciplinary teams of biologists, biochemists and MD's. Antibodies, one of the body’s most important natural defenses, are proteins that seek out, recognize and bind to disease targets. A specific antibody directs the immune system to a particular target like a key fitting into a lock. It is this specificity that makes antibodies potentially useful in various therapeutic applications. Our skilled pre-clinical team, located in Utrecht, ensures that the best possible antibody candidate is selected to become a potential product. A panel of antibodies is generated and these antibodies are put through a rigorous series of laboratory functional assays designed to identify characteristics of the best therapeutic product.
Alliances
At present, Genmab has multiple partnerships to gain access to disease targets and develop novel human antibodies including agreements with GlaxoSmithKline and Roche.Keywords
- Genmab;
- Biotech;
- Human antibodies;
- Monoclonal antibodies;
- Drug discovery;
- Drug development;
- Pre-clinical;
- Oncology;
- Inflammatory diseases;
- Infectious diseases.
